Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131368) titled 'A Study on the Efficacy of the WonderLab Probiotic Product Combination in Weight Management: A Randomized, Double-Blind, Placebo-Controlled Trial' on Sept. 1.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shenzhen New Frontier United Family Hospital
Condition:
Overweight/Obese
Intervention:
Control group:Control product: Placebo (maltodextrin), taken orally after meals, one bottle each in the morning and evening daily, for 90 consecutive days.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-15
Target Sample Size: Control group:39;Trial grou...